跳至主要内容
临床试验/TCTR20210531006
TCTR20210531006已完成1 期

Prevention of bacteremia following impacted lower third molar surgery: A randomized triple-blind controlled trial of 0.3% chlorhexidine mouthrinse and 2-g amoxicillin

Faculty of Dentistry, Prince of Songkla University0 个研究点目标入组 30 人开始时间: 2021年5月31日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 30 Years(—)
性别
All

入选标准

  • 1.Healthy adult patient (20-30 years old)
  • 2.Need of surgical removal of bony impacted mandibular 3rd molar, with partially erupted in oral cavity.
  • 3.No known risk to bacterial endocarditis
  • 4.No signs or symptoms of infection

排除标准

  • 1.Patients with current antibiotic treatment in the past 1 month
  • 2.HbA1c level of 6.5% or higher
  • 3.Patients using routine oral antiseptic mouthrinse
  • 4.Patients using immunosuppressant
  • 5.Patient allergic to chlorhexidine or amoxicillin

研究者

发起方
Faculty of Dentistry, Prince of Songkla University

相似试验